Kfir Molakandov

Director of Diabetes & Innovation at Kadimastem

Dr. Kfir Molakandov started his academic career in developmental biology with Prof. Sarah Ferber's research on transdifferentiation of liver to the pancreas.

During his PhD, he trained at the Gene Therapy Center, Alabama, USA, and specialized in adenoviral vectors construction, modifications and purification. Following the completion of his thesis, Dr. Molakandov joined Kadimastem.

He leads the team that is developing cell-therapy for diabetes using Pluripotent Stem Cells as the cell source. His team has dedicated the last few years in developing a large scale robust protocol for generating islet cells in high quantities and high quality.

Currently, we have finalized the production process that includes a full characterization of the different stages of differentiation using molecular tools and physiological parameters.

Accordingly, we are now moving towards the clinical application of this technology, aiming to bring these therapeutic cells to clinical trials.

Location

Ness Ziona, Israel

Links

Timeline

  • Director of Diabetes & Innovation

    Current role

View in org chart